A 28-year-old primigravida presents for routine antenatal ultrasound at 20 weeks gestation. Detailed fetal anatomy scan reveals a fluid-filled dilatation of the renal pelvis measuring 8 mm in the anteroposterior diameter. The bladder is normal, amniotic fluid volume is adequate, and there are no other structural anomalies. What is the most appropriate next step in management?

Explanation

## Clinical Context This case describes isolated mild fetal pyelectasis (renal pelvic dilatation 8 mm) detected at the 20-week anatomy scan in an otherwise structurally normal fetus. ## Management Algorithm for Fetal Pyelectasis ```mermaid flowchart TD A[Fetal pyelectasis on USG]:::outcome --> B{Measure AP diameter}:::decision B -->|< 7 mm| C[Low risk, routine follow-up]:::action B -->|7-10 mm| D[Mild pyelectasis]:::outcome B -->|> 10 mm| E[Moderate-severe pyelectasis]:::outcome D --> F[Repeat USG at 28-32 weeks]:::action E --> G[Detailed anatomy + Doppler]:::action E --> H[Consider amniocentesis for aneuploidy]:::action F --> I{Resolution or progression?}:::decision I -->|Resolution| J[Postnatal follow-up only]:::action I -->|Progression| K[Postnatal urology evaluation]:::action ``` ## Key Point: **Isolated mild pyelectasis (7–10 mm) at 20 weeks is a soft marker for aneuploidy but does NOT mandate immediate intervention.** The standard approach is serial ultrasound follow-up. ## High-Yield Facts: - **Pyelectasis 7–10 mm** = mild; risk of aneuploidy ~1–2% (minimal increase over baseline). - **Pyelectasis > 10 mm** = moderate-severe; higher aneuploidy risk; consider amniocentesis + detailed anatomy. - **Isolated mild pyelectasis** resolves in ~50% of cases by third trimester. - **No structural anomalies + normal bladder + normal AFV** = reassuring; supports conservative management. ## Clinical Pearl: The **anteroposterior (AP) diameter of the renal pelvis** is the standard measurement. Transverse diameter is less reliable. At 20 weeks, 8 mm is at the upper limit of normal but still classified as mild. ## Next Step Rationale: Repeat ultrasound at 28–32 weeks allows assessment of: 1. Spontaneous resolution (most common outcome). 2. Progression (suggests obstructive uropathy or aneuploidy). 3. Development of other structural or growth abnormalities. This approach balances reassurance with appropriate surveillance without over-investigation.